Pluristem Therapeutics In...

NASDAQ: PSTI · Real-Time Price · USD
1.00
-0.03 (-2.91%)
At close: Jul 26, 2022, 6:00 AM

Pluristem Therapeutics Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2021
Period Ending Jun 30, 2021
Revenue
n/a
Cost of Revenue
n/a
Gross Profit
n/a
Operating Income
-50.62M
Interest Income
492K
Pretax Income
-49.87M
Net Income
-49.87M
Selling & General & Admin
20.56M
Research & Development
30.07M
Other Expenses
n/a
Operating Expenses
50.62M
Interest Expense
78K
Selling & Marketing Expenses
n/a
Cost & Expenses
50.62M
Income Tax Expense
n/a
Shares Outstanding (Basic)
28.11M
Shares Outstanding (Diluted)
28.11M
EPS (Basic)
-1.77
EPS (Diluted)
-1.77
EBITDA
-48.42M
EBIT
-49.79M
Depreciation & Amortization
1.37M